Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

Figure 6

(a) Identifying immune checkpoint genes that are expressed differently in high-risk and low-risk populations. (b) Scores of immunotherapy response in high- and low-risk groups. (c) Spearman’s correlation analysis between model scores and immune cell scores.

(a)

(b)

(c)